Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Anti-Cancer Drug Design|June 17, 1998
Uptake of a boronated epidermal growth factor-dextran conjugate in CHO xenografts with and without human EGF-receptor expressionP Olsson, L Gedda, H Goike, et al.Oncology Reports|February 9, 2006
Astatinated trastuzumab, a putative agent for radionuclide immunotherapy of ErbB2-expressing tumoursM I Persson, L Gedda, H J Jensen, et al.Journal of Molecular Endocrinology|December 6, 2005
Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1M Essand, S Vikman, J Grawé, et al.La Clinica Terapeutica|April 30, 1989
[Socioeconomic status and chronic diseases of the aged. A multicenter study]M Cairella, F Caviezel, F Contaldo, et al.Journal of Neuro-Oncology|May 1, 1997
Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapyS Sjöberg, J Carlsson, H Ghaneolhosseini, et al.International Journal of Radiation Oncology, Biology, Physics|August 30, 1994
Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptorJ Carlsson, L Gedda, C Grönvik, et al.Gene Therapy|April 15, 2011
Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cellsJ Leja, D Yu, B Nilsson, et al.Bioconjugate Chemistry|May 29, 1999
Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistributionV Tolmachev, J Koziorowski, I Sivaev, et al.Acta Oncologica (Stockholm, Sweden)|June 25, 1999
Conjugate chemistry and cellular processing of EGF-dextranJ Carlsson, E Blomquist, L Gedda, et al.British Journal of Cancer|January 15, 2009
Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycinX Wu, A Wanders, P Wardega, et al.Pageof 5